A carregar...
Identification of targeted therapy options for gastric adenocarcinoma by comprehensive analysis of genomic data
BACKGROUND: So far only trastuzumab, pembrolizumab and ramucirumab have been approved by the FDA for targeted therapy in gastric cancer (GC). Here we report on potential targeted therapy options for gastric adenocarcinoma based on a novel analysis of “The Cancer Genome Atlas (TCGA)” database. METHOD...
Na minha lista:
| Publicado no: | Gastric Cancer |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Singapore
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7305081/ https://ncbi.nlm.nih.gov/pubmed/32107691 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10120-020-01045-9 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|